GaryC.BrownMDMBA, Strategic Management

PubMed

• Re: Hughes et al.: Cost-effectiveness analysis of adalimumab for the treatment of uveitis associated with juvenile idiopathic arthritis (Ophthalmology. 2019;126:415-424).
  Gary C. Brown, Melissa M. Brown
  Ophthalmology. 2019-10-01
• 28 citations
  Update on the ocular manifestations of systemic arterial hypertension.
  Betsy Luo, Gary C. Brown
  Current Opinion in Ophthalmology. 2004-06-01
• 133 citations
  The ocular ischemic syndrome. Clinical, fluorescein angiographic and carotid angiographic features.
  Gary C. Brown, Larry E. Magargal
  International Ophthalmology. 1988-02-01

Journal Articles

• Update on Value-Based MedicineC  
  Brown MM. Brown GC, Curr Opin Ophthalmol, 5/1/2013
• Vascular crossing patterns in patients with systemic arterial hypertension  
  Waisbren E, Salz DA Brown GC, Brown MM, Br J Ophthalmol, 4/13/2013
• Serous macular detachment in waldenström macroglobulinemia: a report of four cases  
  Baker PS, Garg SJ, Fineman MS, Chiang A, Alshareef RA, Belmont J, Brown GC, Am J Ophthalmol., 1/1/2013
• Cataract surgery cost-utility revisited in 2012 A new economic paradigm  
  Brown GC, Brown MM, Menezes A, Busbee BG, Lieske HB, Lieske PA, Ophthalmology, 1/1/2013
• Interventions for Toxoplasma Retinochoroiditis: A Report by the American Academy of Ophthalmology  
  Kim SJ, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS, Recchia FM, Ophthalmology, 10/11/2012
• Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response  
  Kaiser RS, Gupta OP, Regillo CD, Ho AC, Fineman MS, Vander JF, McNamara JA, Brown GC, Ophthalmic Surg Lasers Imaging, 1/1/2012
• Ophthalmic Technology Assessment Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema A report by the American Academy of Ophthalmology  
  Ho AC, Scott IU, Kim SJ, Brown GC (methodologist), Brown MM (methodologist), Ip MS, Recchia FM, Ophthalmology, 1/1/2012
• Association between high-risk disease Loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration  
  Orlin A, Hadley D, Chang W, Ho AC, Brown G, Kaiser RS, Regillo CD, Godshalk AN, Lier A, Kaderli B, Stambolian D, Retina, 1/1/2012
• Post-Injection Endophthalmitis (PIE) Study Team Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial gro...  
  Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, Ophthalmology, 10/1/2011
• Comparative effectiveness and cost-effectiveness analyses on the Implantable Miniature Telescope  
  Brown GC, Brown MM, Lieske HB, Lieske PA, Brown KS, Ophthalmology, 9/1/2011
• Psychological and cognitive determinants of vision function in age-related macular degeneration  
  Rovner BW, Casten RJ, Massof RW, Leiby BE, Tasman WS, Benson WE, Brown GC, Federman JL, Fineman MS, Fischer DH, Garg SJ, Ho AC, Hsu J, Kaiser RS, Lucier AC, Maguire JI..., Arch Ophthalmol, 7/1/2011
• Healthcare costs, buyer alert Review  
  Brown MM, Brown GC, Leiske HB, Lieske PA, Curr Opin Ophthalmol, 5/1/2011
• Update on nonsurgical therapy for diabetic macular edema  
  Witkin AJ, Brown GC, Curr Opin Ophthalmol., 5/1/2011
• Diabetes treatment regulation attempt is a portent  
  Brown GC, Wall Street J, 3/24/2011
• Comment on “Walvick MD, Walvick MP Giant cell arteritis: Laboratory predictors of a positive temporal artery biopsy  
  Shareef R, Brown GC, Ophthalmology, 1/1/2011
• Comment on “Walvick MD, Walvick MP Giant cell arteritis: Laboratory predictors of a positive temporal artery biopsy  
  Shareef R, Brown GC, Evidence-Based Ophthalmology, 1/1/2011
• Comment on “Baseline predictors of visual acuity and retinal thickness in patients with retinal vein occlusion: Standard Care Versus Corticosteroid for Retinal Vein Oc...  
  Roth Z, Brown GC, Ophthalmology, 1/1/2011
• Comment on “Baseline predictors of visual acuity and retinal thickness in patients with retinal vein occlusion: Standard Care Versus Corticosteroid for Retinal Vein Oc...  
  Roth Z, Brown GC, Evidence-Based Ophthalmology, 1/1/2011
• Comment on, “Central retinal artery occlusion: Local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial  
  London N, Brown GC. Comment on, Evidence-Based Ophthalmology, 1/1/2011
• Changes in the practice of vitreoretinal disease Editorial  
  Brown GC, Curr Opin Ophthalmol., 1/1/2011
• Editorial Many thanks to all  
  Brown MM, Brown GC, Kertes P, Stein J, Evidence-Based Ophthalmology, 1/1/2011
• Comparative effectiveness and cost-effectiveness analyses: 27,000,000 possible input variants  
  Brown GC, Brown MM, Kertes P, Evidence-Based Ophthalmology Care, 1/1/2011
• Value-Based MedicineR Comparative Effectiveness and Cost-Effectiveness Analyses173% and Counting  
  Brown GC, Brown MM, Kertes P, Lieske HB, Lieske PA. Brown KS, Evidence-Based Ophthalmol, 1/1/2011
• Value-Based MedicineR comparative effectiveness and cost-effectiveness analyses Oral vitamin, and zinc supplements for the treatment of atrophic age-related macular de...  
  Brown GC, Brown MM, Leiske HB, Leiske AP, Brown KS, Evidence-Based Ophthalmol, 1/1/2011
• Value-Based Medicine Analysis Cost-Utility Analysis The foundation of Value-Based Medicine Guidelines to master when performing or evaluating a cost-utility analysis  
  Brown GC, Brown MM, Kertes P, Stein J, Evidence-Based Ophthalmol, 1/1/2011
• Join now to see all